Vietnam selected as Asian pilot country for UK’s new global healthcare partnership

pharmafile | November 19, 2020 | News story | Business Services  

A new global healthcare partnership funded by the World Economic Forum (WEF), the London School of Economics and AstraZeneca has selected Vietnam as its only Asian pilot country for the scheme. 

This is part of the Partnership for Global Health System Sustainability and Resilience (PHSSR) which aims to initiate a multi-sector effort to help health systems foresee, adapt and prevent emerging global health challenges. 

The pilot phase will run from now until January 2021 and will also be implemented in the UK, Germany, France, Italy, Spain, Russia and Poland. PHSSR’s Vietnam team will apply a framework created by the London School of Economics to conduct a rapid review of their health systems sustainability and resilience and also identify solutions to strengthen it. Policy recommendations from this review will inform the WEF’s ‘Great Reset’ which will be announced at a virtual event in January. 

Nitin Kappor, AstraZeneca Vietnam Chairman & General Director, tweeted: “The Partnership for Health System Sustainability & Resilience btwn @wef @LSEHealthPolicy & @AstraZeneca has been launched in Flag of Vietnam as the only Asian country in the pilot phase. Many thanks to @GarethWardUK for hosting, and @SwedeninVN & senior reps from MOH & NGOs for supporting us!”

Gareth Ward, Britain’s Ambassador to Vietnam, also tweeted: “Great initiative by 

@AstraZeneca with @wef and my alma mater @LSEnews. Learning from Flag of Vietnam‘s frugal but innovative health system in these challenging times.”

Conor Kavanagh

Related Content

No items found

Latest content